Lipopolysaccharide enhances transforming growth factor β1-induced platelet-derived growth factor-B expression in bile duct epithelial cells

J Gastroenterol Hepatol. 2012 Apr;27(4):714-21. doi: 10.1111/j.1440-1746.2011.06941.x.

Abstract

Background and aim: Platelet-derived growth factor (PDGF)-B is a potent profibrogenic mediator expressed by bile duct epithelial cells (BDECs) that contributes to liver fibrosis after bile duct ligation. However, the mechanism of PDGF-B induction in BDECs during cholestasis is not known. Transforming growth factor β (TGFβ) and lipopolysaccharide (LPS) also contribute to the profibrogenic response after bile duct ligation. We tested the hypothesis that LPS and TGFβ1 synergistically induce PDGF-B expression in BDECs.

Methods: Transformed human BDECs (MMNK-1 cells) and primary rat BDECs were stimulated with LPS and/or TGFβ1, and signaling pathways through which LPS potentiates TGFβ1-induced PDGF-B mRNA expression were investigated.

Results: Stimulation of MMNK-1 cells with LPS alone did not significantly induce PDGF-B mRNA expression. However, LPS co-treatment enhanced TGFβ1 induction of PDGF-B mRNA in MMNK-1 cells and also in primary rat BDECs. Importantly, co-treatment of MMNK-1 cells with LPS and TGFβ1 also significantly increased PDGF-BB protein expression. Interestingly, LPS did not affect TGFβ1 activation of a SMAD-dependent reporter construct. Rather, stimulation of MMNK-1 cells with LPS, but not TGFβ1, increased JNK1/2 phosphorylation. Expression of dominant negative JNK2, but not dominant negative JNK1, inhibited the LPS potentiation of TGFβ1-induced PDGF-B mRNA expression in MMNK-1 cells. In addition, LPS treatment caused IκBα degradation and activation of a nuclear factor κB (NFκB)-dependent reporter construct. Expression of an IκBα super repressor inhibited activation of NFκB and attenuated LPS potentiation of TGFβ1-induced PDGF-B mRNA.

Conclusions: The results indicate that LPS activation of NFκB and JNK2 enhances TGFβ1-induced PDGF-B expression in BDECs.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Analysis of Variance
  • Animals
  • Bile Ducts / drug effects
  • Bile Ducts / metabolism*
  • Cells, Cultured
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Humans
  • I-kappa B Proteins / metabolism
  • Lipopolysaccharides / pharmacology*
  • Mitogen-Activated Protein Kinase 9 / metabolism
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / metabolism
  • Phosphorylation
  • Proto-Oncogene Proteins c-sis / drug effects
  • Proto-Oncogene Proteins c-sis / metabolism*
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Signal Transduction / drug effects*
  • Smad Proteins / metabolism
  • Statistics, Nonparametric
  • Transforming Growth Factor beta1 / pharmacology*

Substances

  • I-kappa B Proteins
  • Lipopolysaccharides
  • NF-kappa B
  • NFKBIA protein, human
  • Nfkbia protein, rat
  • Proto-Oncogene Proteins c-sis
  • RNA, Messenger
  • Smad Proteins
  • Transforming Growth Factor beta1
  • NF-KappaB Inhibitor alpha
  • Mitogen-Activated Protein Kinase 9